A Cross-Functional, Population-Representative, Web-Based, Epidemiologic

See also
Status	Clinical Trial	Phase
Completed	`NCT01435083` - Desmopressin Melt Therapy in Patients With Nocturnal Polyuria: a Pharmacokinetic/Dynamic Study	Phase 4
Completed	`NCT04520477` - Watershift - Pilot Study	N/A
Recruiting	`NCT05300308` - Lymphoedema and Nocturia/Nocturnal Polyuria After Pelvic LND for Urogenital Cancer

See also

Status

Clinical Trial

Phase

Completed

NCT01435083 - Desmopressin Melt Therapy in Patients With Nocturnal Polyuria: a Pharmacokinetic/Dynamic Study

Phase 4

Completed

NCT04520477 - Watershift - Pilot Study

N/A

Recruiting

NCT05300308 - Lymphoedema and Nocturia/Nocturnal Polyuria After Pelvic LND for Urogenital Cancer

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT04125186
Study type	Observational
Source	Ferring Pharmaceuticals
Contact
Status	Completed
Phase
Start date	July 22, 2019
Completion date	June 30, 2020

A Cross-Functional, Population-Representative, Web-Based, Epidemiologic Study to Estimate the Prevalence and Burden of Nocturia Due to Nocturnal Polyuria in the US

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms